Lithium Controlled-Release and Extended-Release Tablets and Tranexamic acid
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Tranexamic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: tranexamic acid
Brand name: Cyklokapron, Lysteda
Synonyms: Tranexamic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Tranexamic Acid Injection
- Lithium Controlled-Release and Extended-Release Tablets-Tranexamic acid Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Tranexamic Acid Tablet
- Lithium Controlled-Release and Extended-Release Tablets-Tranexamic Acid Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Tranquil
- Lithium Controlled-Release and Extended-Release Tablets-Transanosil
- Tranexamic acid-Lithium ER
- Tranexamic acid-Lithium Oral Solution
- Tranexamic acid-Lithium Salts
- Tranexamic acid-Lithium Syrup and Oral Solution
- Tranexamic acid-Lithobid
- Tranexamic acid-Lithostat